Cirsimarin, a potent antilipogenic flavonoid, decreases fat deposition in mice intra-abdominal adipose tissue

International Journal of Obesity

Volumn 34, Issue 11, 2010, Pages 1566-1575

  Zarrouki, B ^a,b,c,d   Pillon, N J ^a,b,c,d   Kalbacher, E ^a,b,c,d,e   Soula, H A ^a,b,c,d   Nia N'Jomen, G ^a,b,c,d   Grand, L ^f   Chambert, S ^f   Geloen, A ^a,b,c,d   Soulage, C O ^a,b,c,d  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

^c INSERM   (France)

^d UNIVERSITÉ LYON 1   (France)

^e HOSPICES CIVILS DE LYON   (France)

^f UNIVERSITÉ LYON 1   (France)

Author keywords

cellularity; cirsimarin; flavonoid; lipogenesis; white adipose tissue

Indexed keywords

ANTIOBESITY AGENT; CIRSIMARIN; FLAVONOID; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADIPOCYTE; ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CELL VOLUME; CONTROLLED STUDY; DRUG BLOOD LEVEL; EPIDIDYMIS FAT; IC 50; IN VIVO STUDY; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ANIMALS; BODY WEIGHT; CELL COUNT; CELL SIZE; FLAVONES; GLYCOSIDES; INJECTIONS, INTRAPERITONEAL; INTRA-ABDOMINAL FAT; LIPOGENESIS; MALE; MICE; RATS;

MUS; RATTUS;

EID: 78349309870     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.85     Document Type: Article

References (45)

1. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002; 22: 19-34.
2. Arts ICW, Hollman PCH. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005; 81 (1 Suppl): 317S-325S.
3. Choi E, Hwang J. Effect of some medicinal plants on plasma antioxidant system and lipid levels in rats. Phytother Res 2005; 19: 382-386.
4. Kris-Etherton PM, Lefevre M, Beecher GR, Gross MD, Keen CL, Etherton TD. Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu Rev Nutr 2004; 24: 511-538.
5. Nagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y et al. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr 2005; 81: 122-129.
6. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 2007; 15: 1473-1483.
7. Wolfram S, Wang Y, Thielecke F. Anti-obesity effects of green tea: from bedside to bench. Mol Nutr Food Res 2006; 50: 176-187.
8. Kuppusamy UR, Das NP. Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochem Pharmacol 1992; 44: 1307-1315.
9. Liang H, Belardinelli L, Ozeck MJ, Shryock JC. Tonic activity of the rat adipocyte A1-adenosine receptor. Br J Pharmacol 2002; 135: 1457-1466.
10. Honnor RC, Dhillon GS, Londos C. cAMP-dependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior. J Biol Chem 1985; 260: 15122-15129.
11. Honnor RC, Dhillon GS, Londos C. cAMP-dependent protein kinase and lipolysis in rat adipocytes. II. Definition of steady-state relationship with lipolytic and antilipolytic modulators. J Biol Chem 1985; 260: 15130-15138.
12. Hasrat JA, De Bruyne T, De Backer JP, Vauquelin G, Vlietinck AJ. Cirsimarin and cirsimaritin, flavonoids of Microtea debilis (Phytolaccaceae) with adenosine antagonistic properties in rats: leads for new therapeutics in acute renal failure. J Pharm Pharmacol 1997; 49: 1150-1156.
13. Hasrat JA, Pieters L, Claeys M, Vlietinck A, De Backer JP, Vauquelin G. Adenosine-1 active ligands: cirsimarin, a flavone glycoside from Microtea debilis. J Nat Prod 1997; 60: 638-641.
14. Girotti C, Ginet M, Demarne FC, Lagarde M, Géloën A. Lipolytic activity of cirsimarin extracted from Microtea debilis. Planta Med 2005; 71: 1170-1172.
15. Kavvadias D, Sand P, Youdim KA, Qaiser MZ, Rice-Evans C, Baur R et al. The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects. Br J Pharmacol 2004; 142: 811-820.
16. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509.
17. Rodbell M. Metabolism of isolated fat cells. I. effects of hormones on glucose metabolism and lipolysis. J Biol Chem 1964; 239: 375-380.
18. Briquet-Laugier V, Dugail I, Ardouin B, Le Liepvre X, Lavau M, Quignard-Boulangé A. Evidence for a sustained genetic effect on fat storage capacity in cultured adipose cells from Zucker rats. Am J Physiol 1994; 267 (3 Part 1): E439-E446.
19. Smith U, Sjöström L, Björnstorp P. Comparison of two methods for determining human adipose cell size. J Lipid Res 1972; 13: 822-824.
20. Björnheden T, Jakubowicz B, Levin M, Odén B, Edén S, Sjöström L et al. Computerized determination of adipocyte size. Obes Res 2004; 12: 95-105.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
22. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980; 102: 344-352.
23. Cohen J, Mares V, Lodin Z. DNA content of purified preparations of mouse Purkinje neurons isolated by a velocity sedimentation technique. J Neurochem 1973; 20: 651-657.
24. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev (Internet) 28 July 2009; available from: 2009 http://www.ncbi.nlm.nih.gov/pubmed/19656312.
25. Szkudelska K, Nogowski L, Szkudelski T. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J Steroid Biochem Mol Biol 2000; 75: 265-271.
26. Naaz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB et al. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 2003; 144: 3315-3320.
27. Formica JV, Regelson W. Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol 1995; 33: 1061-1080.
28. Fuhr U, Kummert AL. The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin Pharmacol Ther 1995; 58: 365-373.
29. Smith S. The animal fatty acid synthase: one gene, one polypeptide, seven enzymes. FASEB J 1994; 8: 1248-1259.
30. Wakil SJ. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 1989; 28: 4523-4530.
31. Chirala SS, Wakil SJ. Structure and function of animal fatty acid synthase. Lipids 2004; 39: 1045-1053.
32. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000; 288: 2379-2381.
33. Li BH, Tian WX. Inhibitory effects of flavonoids on animal fatty acid synthase. J Biochem 2004; 135: 85-91.
34. Thupari JN, Kim E, Moran TH, Ronnett GV, Kuhajda FP. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass. Am J Physiol Endocrinol Metab 2004; 287: E97-E104.
35. Tu Y, Thupari JN, Kim E, Pinn ML, Moran TH, Ronnett GV et al. C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure. Endocrinology 2005; 146: 486-493.
36. Cha SH, Hu Z, Lane MD. Long-term effects of a fatty acid synthase inhibitor on obese mice: food intake, hypothalamic neuropeptides, and UCP3. Biochem Biophys Res Commun 2004; 317: 301-308.
37. Dridi S, Ververken C, Hillgartner FB, Arckens L, Lutgarde A, Van der Gucht E et al. FAS inhibitor cerulenin reduces food intake and melanocortin receptor gene expression without modulating the other (an)orexigenic neuropeptides in chickens. Am J Physiol Regul Integr Comp Physiol 2006; 291: R138-R147.
38. Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 2002; 51: 271-275.
39. Kim E, Miller I, Aja S, Landree LE, Pinn M, McFadden J et al. C75, a fatty acid synthase inhibitor, reduces food intake via hypo-thalamic AMP-activated protein kinase. J Biol Chem 2004; 279: 19970-19976.
40. Landree LE, Hanlon AL, Strong DW, Rumbaugh G, Miller IM, Thupari JN et al. C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism. J Biol Chem 2004; 279: 3817-3827.
41. Pedersen SB, Børglum JD, Møller-Pedersen T, Richelsen B. Effects of in vivo estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes. Mol Cell Endocrinol 1992; 85: 13-19.
42. Cooke PS, Heine PA, Taylor JA, Lubahn DB. The role of estrogen and estrogen receptor-alpha in male adipose tissue. Mol Cell Endocrinol 2001; 178: 147-154.
43. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002; 76: 1191-1201.
44. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-4263.
45. Farmakalidis E, Hathcock JN, Murphy PA. Oestrogenic potency of genistin and daidzin in mice. Food Chem Toxicol 1985; 23: 741-745.